RecruitingNot ApplicableNCT06507228

North West London Pebble Pathway: Automated OSA Diagnosis


Sponsor

Patrik Bachtiger

Enrollment

200 participants

Start Date

Jul 7, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Patients with obstructive sleep apnoea (OSA) wait up to two years for a diagnostic test. Early diagnosis enables optimal treatment, mitigating risks including heart failure, lung disease, and stroke. Current diagnostic approaches are expensive (£391), time-consuming (\>1-hour interpretation), uncomfortable (cables/tubes/wires), and inequitable (multiple hospital visits). Overcoming all these limitations, we have designed and will investigate a straigh-to-test automated diagnostic pathway for OSA. This will use the AcuPebble, a miniature wearable acoustic sensor and the first regulated technology for automated, at-home diagnosis. The test is cheap (\< £100); time-saving; endorsed by patients, and accessible (posted directly to patients). This project will measure the impact of a potentially transformative, innovative, and scalable diagnostic pathway using AcuPebble technology.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • OSA testing referral from primary care

Exclusion Criteria1

  • Unable to follow test instructions

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTNWL PEBBLE STT

At home testing for OSA with AcuPebble.


Locations(1)

Charing Cross Hospital

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06507228


Related Trials